Header

UZH-Logo

Maintenance Infos

Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts


Byonanebye, Dathan M; Polizzotto, Mark N; Maltez, Fernando; Rauch, Andri; Grabmeier-Pfistershammer, Katharina; Wit, Ferdinand; De Wit, Stephane; Castagna, Antonella; d'Arminio Monforte, Antonella; Mussini, Cristina; Wasmuth, Jan-Christian; Fontas, Eric; Abela, Irene; Sarcletti, Mario; Bansi-Matharu, Loveleen; Jaschinski, Nadine; Peters, Lars; Hosein, Sean R; Vannappagari, Vani; Cohen, Cal; Bissio, Emiliano; Mocroft, Amanda; Law, Matthew; Ryom, Lene; Petoumenos, Kathy (2024). Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts. The Lancet : HIV, 11(5):e321-e332.

Statistics

Citations

Dimensions.ai Metrics

Altmetrics

Downloads

1 download since deposited on 22 May 2024
1 download since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Infectious Diseases
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Epidemiology
Life Sciences > Immunology
Health Sciences > Infectious Diseases
Life Sciences > Virology
Language:English
Date:May 2024
Deposited On:22 May 2024 10:56
Last Modified:11 Jul 2024 03:18
Publisher:Elsevier
ISSN:2352-3018
OA Status:Closed
Publisher DOI:https://doi.org/10.1016/s2352-3018(23)00328-4
PubMed ID:38621392